Nestle in talks over US$10bil sale of skin health unit to EQT, ADIA

  • Business
  • Friday, 17 May 2019

Nestle is among the eight companies which Maybank IB is issuing the call warrants over the shares.

ZURICH: Nestle SA has entered exclusive negotiations to sell its skin health business to a consortium led by EQT Partners and Abu Dhabi’s ADIA in a deal worth 10.2 billion Swiss francs (US$10.12bil), it said.

The proposed transaction with private equity firm EQT and a unit of the Abu Dhabi Investment Authority was expected to close in the second half of 2019, pending regulatory approval, it said.

Nestle will provide an update on how it will use the proceeds and its future capital structure at that time, the world’s biggest packaged food group said in a statement.

Nestle shares were indicated 0.6% higher in pre-market activity.

Reuters and the Financial Times had reported on Wednesday that EQT was putting the finishing touches to the deal.

Nestle chief executive Mark Schneider put the skin health unit up for sale last September as the group moved to ditch underperforming businesses in an effort to fend off criticism from an activist investor who wanted an overhaul.

Nestle Skin Health, which sells Cetaphil and Proactiv skin care products, Restylane wrinkle fillers and prescription dermatology medicines, had sales of 2.8 billion Swiss francs last year.

Nestle created the unit in 2014 when it bought out L’Oreal’s stake in their Galderma joint venture. — Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3

Nestle , skin health unit , sale , EQT , ADIA ,


Did you find this article insightful?


Across the site